{"title":"COVID-19: A novel strain challenging the human race","authors":"V. Ranganathan, Padma Madham, Arpitha Somayaji","doi":"10.15406/JMEN.2020.08.00292","DOIUrl":null,"url":null,"abstract":"Diseases are not new to the humans’ as we have learnt to cope up with a variety of contagion and contagious infections. Way back in the 18 th century cowpox was a terrorizing clinical condition and as time progressed, the era of rabies and TB was an issue of health concern. But time has been the eternal evidence to validate the fight of mankind against these clinical manifestations. However, over the last few months, the world is being taken by a swing by an invisible, nanoscopic biological particle which was later named as COVID-19 or in short form is represented as nCoV-19 where n designate the uniqueness of the virus and is rightly called as novel corona virus 19 (nCoV-19). Though the outbreak of the pandemic gained its pace in 2020, it was initially discovered in December 2019 in the Wuhan province of China. Hence the virus is represented with 19 as a suffix. The disease which initially started as an epidemic soon started its universal form and became a severe pandemic all over the globe. The current article is an attempt to comprehend the facets of COVID-19 otherwise called as novel corona virus which is very often compared to the SARS outbreak in 2002 in China. The article also attempts to disclose various measures undertaken by the government and private firms to curb the intensity of the contagion. The current article emphasizes on clinical signs and epidemiological characteristics of novel corona virus disease and endeavors to brief out the possible steps to curd the rapid spreading of the disease.","PeriodicalId":91326,"journal":{"name":"Journal of microbiology & experimentation","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of microbiology & experimentation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JMEN.2020.08.00292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Diseases are not new to the humans’ as we have learnt to cope up with a variety of contagion and contagious infections. Way back in the 18 th century cowpox was a terrorizing clinical condition and as time progressed, the era of rabies and TB was an issue of health concern. But time has been the eternal evidence to validate the fight of mankind against these clinical manifestations. However, over the last few months, the world is being taken by a swing by an invisible, nanoscopic biological particle which was later named as COVID-19 or in short form is represented as nCoV-19 where n designate the uniqueness of the virus and is rightly called as novel corona virus 19 (nCoV-19). Though the outbreak of the pandemic gained its pace in 2020, it was initially discovered in December 2019 in the Wuhan province of China. Hence the virus is represented with 19 as a suffix. The disease which initially started as an epidemic soon started its universal form and became a severe pandemic all over the globe. The current article is an attempt to comprehend the facets of COVID-19 otherwise called as novel corona virus which is very often compared to the SARS outbreak in 2002 in China. The article also attempts to disclose various measures undertaken by the government and private firms to curb the intensity of the contagion. The current article emphasizes on clinical signs and epidemiological characteristics of novel corona virus disease and endeavors to brief out the possible steps to curd the rapid spreading of the disease.